The efficacy, safety, and satisfaction associated with switching from brinzolamide or brimonidine to brinzolamide/brimonidine in open-angle glaucoma patients

HIGHLIGHTS

• who: Hiromitsu Onoe and colleagues from the Department of Ophthalmology and Visual Science, Hiroshima University, Hiroshima, Japan have published the research: The Efficacy, Safety, and Satisfaction Associated with Switching from Brinzolamide or Brimonidine to Brinzolamide/Brimonidine in Open-Angle Glaucoma Patients, in the Journal: (JOURNAL)
• what: The authors investigated the efficacy, safety, and satisfaction in patients who were switched from brinzolamide 1% or brimonidine 0.1% to BBFC. An insufficient IOP was the main reason why patients were switched to BBFC. The analysis showed that there was an increase in both the convenience and satisfaction . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.